Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,624
Total Claims
$1.1M
Drug Cost
528
Beneficiaries
$2,089
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+78%
Cost per patient vs peers
$2,089 vs $1,174 avg
+82%
Brand preference vs peers
16.2% vs 8.9% avg
Brand vs Generic
Brand: 1,371 claims · $924K
Generic: 7,103 claims · $168K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Lipase/Protease/Amylase | 173 | $209K |
| Semaglutide | 54 | $73K |
| Apixaban | 102 | $69K |
| Linaclotide | 97 | $66K |
| Empagliflozin | 31 | $39K |
| Dapagliflozin Propanediol | 50 | $37K |
| Lipase/Protease/Amylase | 49 | $31K |
| Rivaroxaban | 32 | $29K |
| Dulaglutide | 19 | $27K |
| Tirzepatide | 20 | $27K |
| Insulin Glargine,hum.Rec.Anlog | 28 | $18K |
| Lidocaine | 87 | $15K |
| Sitagliptin Phosphate | 19 | $15K |
| Semaglutide | 11 | $13K |
| Sitagliptin Phos/Metformin Hcl | 22 | $13K |
Prescribing Profile
Patient Profile
74
Avg Age
67%
Female
1.25
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data